Unibest
← Back to patent-cliff list

SVT-15652

Tier C — Watch / trade

SVT-15652

Laboratorios Salvat Sa
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Updating

Indications (approved):耳真菌病

Regional status

US
Phase III
2020-02-27
EU
Phase III
2020-06-09
China
-
Japan
-

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of SVT-15652?

Approved indications include: 耳真菌病.

When does the SVT-15652 patent expire?

No public expiry year is available for SVT-15652 yet; this page updates once verified.

How do I get a quote for SVT-15652 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-07